CVKD – cadrenal therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Favourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stock [Yahoo! Finance]
Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024 [Yahoo! Finance]
Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts [Yahoo! Finance]
Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
Form 4 Cadrenal Therapeutics, For: Apr 10 Filed by: Pham Quang X
Form 8-K Cadrenal Therapeutics, For: Apr 09
Form 4 Cadrenal Therapeutics, For: Apr 02 Filed by: Cole Jeffrey Scott
Form 3 Cadrenal Therapeutics, For: Feb 07 Filed by: Cole Jeffrey Scott
Form EFFECT Cadrenal Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.